Research view
Switch to patient viewGroups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
One card per institution. Pick a target to see only the groups that work on it.
The University of Texas MD Anderson Cancer Center · Houston, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Mod Pathol, Mar 2026Comprehensive Cytogenomic Profiling of T-Lymphoblastic Leukemia Using Optical Genome Mapping, Karyotyping, and Next-Generation Sequencing.
New York, United States
Duarte, United States
Los Angeles, United States
Buffalo, United States
5 of 5+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.
No running funded project names this disease yet.
Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.
Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.
Terminated
A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS
“Change in corporate strategy”Registry text, quoted unchanged. SourceTrials whose registry record says individual participant data (IPD) will be shared.
No trial in this view states that it shares participant data.
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed, NIH RePORTER, CORDIS. Machine-matched links are labelled.